EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic potential of ginseng leaf extract in inhibiting mast cell-mediated allergic inflammation and atopic dermatitis-like skin inflammation in DNCB-treated mice

Jung-Mi Oh, HyunHo Yoon, Jae-Yeol Joo, Wan-Taek Im, Sungkun Chun

Frontiers in Pharmacology · 22.05.2024 · 15

DOI: 10.3389/fphar.2024.1403285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.05.2024. Verfasst von Jung-Mi Oh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do, Republic of Korea. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ginseng leaves are known to contain high concentrations of bioactive compounds, such as ginsenosides, and have potential as a treatment for various conditions, including fungal infections, cancer, obesity, oxidative stress, and age-related diseases. This study assessed the impact of ginseng leaf extract (GLE) on mast cell-mediated allergic inflammation and atopic dermatitis (AD) in DNCB-treated mice. GLE reduced skin thickness and lymph node nodules and suppressed the expression and secretion of histamine and pro-inflammatory cytokines. It also significantly lowered the production of inflammatory response mediators including ROS, leukotriene C4 (LTC4), prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). GLE inhibited the phosphorylation of MAPKs (ERK, P38, JNK) and the activation of NF-κB, which are both linked to inflammatory cytokine expression. We demonstrated that GLE’s inhibitory effect on mast cell-mediated allergic inflammation is due to the blockade of the NF-κB and inflammasome pathways. Our findings suggest that GLE can be an effective therapeutic agent for mast-cell mediated and allergic inflammatory conditions.

Schlagwörter

Stichwörter der Autor:innen

MAPKNF-κBanti-inflammatorydegranulationginseng leaf extractinflammasomepro-inflammatory cytokines

Autor:innen und Institutionen

  • Department of Physiology, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea.
  • Department of Biological Sciences, Hankyong National University, Anseong, Gyeonggi-do, Republic of Korea.

Zitieren

APA

Oh, J. M., Yoon, H., Joo, J. Y., Im, W. T., & Chun, S. (2024). Therapeutic potential of ginseng leaf extract in inhibiting mast cell-mediated allergic inflammation and atopic dermatitis-like skin inflammation in DNCB-treated mice. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1403285

Vancouver

Oh JM, Yoon H, Joo JY, Im WT, Chun S. Therapeutic potential of ginseng leaf extract in inhibiting mast cell-mediated allergic inflammation and atopic dermatitis-like skin inflammation in DNCB-treated mice. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1403285

BibTeX
@article{Oh2024,
  author = {Oh, Jung-Mi and Yoon, HyunHo and Joo, Jae-Yeol and Im, Wan-Taek and Chun, Sungkun},
  title = {Therapeutic potential of ginseng leaf extract in inhibiting mast cell-mediated allergic inflammation and atopic dermatitis-like skin inflammation in DNCB-treated mice},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1403285}
}
Kostenlos starten →